What Is Dihexa? Dosage, Half-Life & How to Track It

What Dihexa is and how it works

Dihexa is a synthetic small molecule developed from research into angiotensin IV, a fragment of the angiotensin hormone system best known for regulating blood pressure. Researchers at Washington State University modified that fragment to dramatically increase its potency and, notably, its ability to cross the blood-brain barrier and survive oral dosing — unlike most peptides, which are broken down in the gut.

Its proposed mechanism runs through the HGF/c-Met pathway — the same signaling system hepatocyte growth factor uses to drive tissue growth in the liver, but here studied for its effect on neurons. In rodent studies, Dihexa produced a marked increase in synaptogenesis, the formation of new synaptic connections, and reversed cognitive deficits in aged and impaired animals at doses far lower than comparable compounds.

Worth being direct about this one: virtually all of the evidence is preclinical (rodent) research from a single research group, there is no published human trial data, and it is not approved or reviewed for human use anywhere. Of the nootropics in this library, Dihexa has some of the most striking animal data and some of the thinnest human evidence — those two things are not in tension, they are just the state of the research.

Typical dosing & administration

Dihexa is unusual among research compounds discussed alongside peptides because it is genuinely orally bioavailable — it does not need to be injected to work, which is part of what made it interesting to researchers in the first place. Community oral protocols vary widely, commonly citing 2–20 mg once daily, dissolved or held sublingually; some vendors also sell it as a reconstituted injectable for subcutaneous use at similar or lower per-dose amounts.

Because there is no clinical dosing standard, any number here is a community estimate rather than a validated protocol. If using an injectable version, it is reconstituted with bacteriostatic water like a standard peptide vial — a 10 mg vial in 2 mL BAC water gives roughly 5 mg/mL, so a 2 mg dose is 40 units on a U-100 insulin syringe. The reconstitution calculator handles that math for whatever vial and water amount is actually on hand, but oral use is the more commonly discussed route.

Half-life & what it means for frequency

There is no published human half-life for Dihexa — pharmacokinetic characterization this specific has not made it into peer-reviewed literature, and animal PK data has not been consistently translated into a human-relevant number. Once-daily dosing is a community convention, not something derived from measured blood levels.

What is worth noting is the oral route itself: because Dihexa survives gut absorption (unusual for anything in this class), its exposure profile is likely governed more by absorption and first-pass metabolism than by the fast peptide-style clearance seen elsewhere in this library — but that is an inference from its chemistry, not a measured fact.

What to track & common side effects

Because there is no human trial data, there is no established human side-effect profile. Animal studies have not reported significant toxicity at studied doses, but that does not translate into a safety guarantee for people, and long-term human exposure has never been studied at any dose.

Given how thin the evidence is, the most useful thing to track is basic safety monitoring — any new or unusual symptom — alongside the dose, route, and whatever cognitive marker motivated trying it, so a reaction or a benefit can be traced back to a specific change rather than guessed at.

Frequently asked questions